You are here: Industry Insights > advance

News List

Amgen looks to expand access to Otezla in the US pharmatimes
February 24, 2021
Amgen has submitted a supplemental new drug application (sNDA) seeking expanded approval for Otezla in adults with mild-to-moderate plaque psoriasis who are candidates for phototherapy or systemic therapy.
Risankizumab trials show higher clinical remission in patients with Crohn’s disease europeanpharmaceuticalreview
January 12, 2021
Two Phase III trials have shown that two doses of risankizumab met the primary endpoints in patients with Crohn’s disease.
Amgen Announces Positive Top-Line Results from Otezla Plaque Psoriasis Study americanpharmaceuticalreview
May 08, 2020
Amgen announced positive top-line results from the ADVANCE trial, a Phase 3, multicenter, randomized, placebo-controlled, double-blind study to assess the efficacy of Otezla® (apremilast) in adults with mild-to-moderate plaque psoriasis.
Orum Therapeutics raises $30M to advance Ab technology fiercepharma
July 22, 2019
Financing proceeds to fund further platform development and therapeutic discovery in cancer and rare diseases
Merck joins TRANSVAC2 programme to advance vaccine development biospectrumasia
May 21, 2019
TRANSVAC2, part of the EU's Horizon 2020 program, provides trainings to streamline vaccine manufacturing and development
FDA takes new steps to advance natural history studies for accelerating novel treatments for rare diseases firstwordpharma
March 23, 2019
One key way we’ve addressed these opportunities is by providing funding for rare disease natural history ……